Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Meningiomas are the most common primary intracranial tumors in adults and are increasing
in incidence due to the aging population and increased access to neuroimaging. While most …
in incidence due to the aging population and increased access to neuroimaging. While most …
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Abstract Treatment of the tumor and dural margin with surgery and sometimes radiation are
cornerstones of therapy for meningioma. Molecular classifications have provided insights …
cornerstones of therapy for meningioma. Molecular classifications have provided insights …
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature
G Piperno, A Ferrari, S Volpe, F Cattani… - Critical Reviews in …, 2023 - Elsevier
Aims Aim of the present analysis was to report results of a systematic review of the literature
in the setting of patients treated with hypoF PT for benign lesions of the central nervous …
in the setting of patients treated with hypoF PT for benign lesions of the central nervous …
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Surgery is the mainstay of treatment for meningioma, the most common primary intracranial
tumor, but improvements in meningioma risk stratification are needed and indications for …
tumor, but improvements in meningioma risk stratification are needed and indications for …
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Intratumor heterogeneity underlies cancer evolution and treatment resistance, but targetable
mechanisms driving intratumor heterogeneity are poorly understood. Meningiomas are the …
mechanisms driving intratumor heterogeneity are poorly understood. Meningiomas are the …
RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups
Background Advances in our understanding of the molecular biology of meningiomas have
led to significant gains in the ability to predict patient prognosis and tumor recurrence and to …
led to significant gains in the ability to predict patient prognosis and tumor recurrence and to …
Interdisciplinary therapeutic approaches to atypical and malignant meningiomas
L Trakolis, AK Petridis - Cancers, 2023 - mdpi.com
Simple Summary Recent advances in diagnostics and adjuvant therapy regarding
meningiomas have called into question the oncological relevance of gross total removal …
meningiomas have called into question the oncological relevance of gross total removal …
A bibliometric analysis of radiation-induced brain injury: a research of the literature from 1998 to 2023
J Lan, Y Ren, Y Liu, L Chen, J Liu - Discover Oncology, 2024 - Springer
Background Radiation-induced brain injury (RIBI) is a debilitating sequela after cranial
radiotherapy. Research on the topic of RIBI has gradually entered the public eye, with more …
radiotherapy. Research on the topic of RIBI has gradually entered the public eye, with more …
[HTML][HTML] Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Background Surgery is the mainstay of treatment for meningioma, the most common primary
intracranial tumor, but improvements in meningioma risk stratification are needed and …
intracranial tumor, but improvements in meningioma risk stratification are needed and …
[HTML][HTML] Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution
Intratumor heterogeneity underlies cancer evolution and treatment resistance 1–5, but
targetable mechanisms driving intratumor heterogeneity are poorly understood …
targetable mechanisms driving intratumor heterogeneity are poorly understood …